Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Background: Cervical cancer is a malignant neoplasm arising from cells originating in the cervix uteri. Unlike most cancers, cervical
cancer has a central causal factor, which is the Human Papilloma Virus (HPV). The Papanicoloau (Pap) screening test is currently the
most widely used diagnostic and screening tool in detecting the presence of cervical cancer.
Aim: The study aimed at investigating the five � year survival rate of cervical cancer patients treated at the Radiotherapy Center,
Korle-Bu Teaching Hospital, Accra, Ghana.
Methods: A quantitative retrospective cohort design was used which involved reviewing 100 medical records of cervical cancer
patients who received radiotherapy between 2007 and 2008 at the Radiotherapy center. Ethical approval was sought from the Ethics
and Protocol Review Committee of School of Biomedical and Allied Health Sciences, University of Ghana Follow-up contacts were
made to the patients to collect the data for the study. Where patients were not alive, their next of kin were interviewed. Descriptive
statistics was used to determine frequencies and percentages of tumour stage, age and other factors and their effect on the overall
survival rates of patients.
Results: The five-year survival rate of 41% was observed for all the patients. However, patients who received radical radiotherapy had
a higher survival rate of 86.7%.
Conclusion: The age of the patients, the tumor stage, and the type of treatment used influenced the survival rate of patients.